Materials • Major Chemicals
$5.13 ▼ -0.45
(-8.06%)
MKT CAP: $73.0M • VOL: 171.9K
52W L $4 52W H $44
ROARABLE / RQD
E • 26/100
PIOTROSKI
3 / 9
LNZA // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $55.8M | $49.6M | $62.6M |
| YoY Revenue Growth % | +12.6% | -20.8% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$79.2M | -$108.9M | -$106.4M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | -$49.0M | -$137.7M | -$134.1M |
| EBITDA (Normalized) | -$78.1M | -$104.7M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$64.9M | -$89.1M | -$97.3M |
| Capital Expenditures (CapEx) | $1.3M | $5.3M | — |
| Free Cash Flow (FCF) | -$66.1M | -$94.4M | -$97.3M |
| FCF Margin % | -80.0% | -80.0% | -80.0% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $13.2M | $43.5M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | -$3.9M | $13.4M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR LNZA.